Security key
005111109
Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB)
CUSIP: 005111109
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 60,359,615
- Total 13F shares
- 6,592,463
- Share change
- -402,811
- Total reported value
- $1,238,563
- Price per share
- $0.19
- Number of holders
- 21
- Value change
- -$76,859
- Number of buys
- 5
- Number of sells
- 13
Report period
Q1 2024
Institutions
21
Top holders
10
AFIB full security history
Newer quarter: Q2 2024
Previous quarter: Q4 2023
Acutus Medical, Inc. SEC filings
Acutus Medical, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 005111109
Recent filing periods:
Top shareholders of AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
4.4%
|
2,660,808
|
$537,217 | — | 31 Dec 2023 | |
| ORBIMED ADVISORS LLC |
3/4/5
13F
|
Director, 10%+ Owner · Company |
4.4%
from 13F
|
1,677,361
|
$2,616,683 | — | 19 Jul 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.54%
|
327,000
|
$66,000 | — | 31 Dec 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.47%
|
286,084
|
$57,761 | — | 31 Dec 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.34%
|
206,681
|
$41,729 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.34%
|
206,624
|
$41,733 | — | 31 Dec 2023 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.2%
|
117,926
|
$23,000 | — | 31 Dec 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.19%
|
113,657
|
$22,947 | — | 31 Dec 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.18%
|
107,673
|
$21,739 | — | 31 Dec 2023 | |
| Virtu Financial LLC |
13F
|
Company |
0.12%
|
75,031
|
$15,000 | — | 31 Dec 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.09%
|
51,871
|
$10,473 | — | 31 Dec 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
35,038
|
$7,074 | — | 31 Dec 2023 | |
| HBK Sorce Advisory LLC |
13F
|
Company |
0.05%
|
30,000
|
$6,057 | — | 31 Dec 2023 | |
| NICOLET ADVISORY SERVICES, LLC |
13F
|
Company |
0.04%
|
21,300
|
$4,026 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
17,541
|
$3,542 | — | 31 Dec 2023 | |
| Westside Investment Management, Inc. |
13F
|
Company |
0.03%
|
17,000
|
$3,433 | — | 31 Dec 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
11,764
|
$2,376 | — | 31 Dec 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
11,391
|
$2,300 | — | 31 Dec 2023 | |
| FIRST BUSINESS FINANCIAL SERVICES, INC. |
13F
|
Company |
0.02%
|
10,000
|
$2,019 | — | 31 Dec 2023 | |
| VOISARD ASSET MANAGEMENT GROUP, INC. |
13F
|
Company |
0.01%
|
8,700
|
$1,757 | — | 31 Dec 2023 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
6,825
|
$1,379 | — | 31 Dec 2023 | |
| S.A. Mason LLC |
13F
|
Company |
0.01%
|
6,400
|
$1,292 | — | 31 Dec 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
6,235
|
$1,259 | — | 31 Dec 2023 | |
| AdvisorNet Financial, Inc |
13F
|
Company |
0.01%
|
5,625
|
$1,136 | — | 31 Dec 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
3,229
|
$652 | — | 31 Dec 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0%
|
1,685
|
$340 | — | 31 Dec 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
800
|
$160 | — | 31 Dec 2023 | |
| Shahzad Malik |
3/4/5
|
Director |
—
mixed-class rows
|
1,562,757
mixed-class rows
|
$2,426,946 | — | 17 Jun 2021 | |
| James F. Hinrichs. |
3/4/5
|
Director |
—
mixed-class rows
|
95,910
mixed-class rows
|
$119,043 | — | 16 Jun 2022 | |
| R. Scott Huennekens |
3/4/5
|
Director |
—
class O/S missing
|
529,349
|
$100,047 | — | 15 Jun 2023 | |
| Vincent J. Burgess |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
61,469
|
$95,892 | — | 01 Apr 2022 | |
| Steven McQuillan |
3/4/5
|
SVP, Clinical Affairs & QA |
—
class O/S missing
|
45,844
|
$71,517 | — | 01 Apr 2022 | |
| David Roman |
3/4/5
|
President & CEO |
—
class O/S missing
|
332,134
|
$62,773 | — | 07 Jan 2024 | |
| Tom Sohn |
3/4/5
|
SVP, Gen. Counsel & Secretary |
—
class O/S missing
|
105,009
|
$18,167 | — | 06 Feb 2024 | |
| Daniella Cramp |
3/4/5
|
Director |
—
mixed-class rows
|
31,223
mixed-class rows
|
$18,132 | — | 16 Jun 2022 | |
| Charlie Piscitello |
3/4/5
|
SVP, Chief People Officer |
—
class O/S missing
|
85,683
|
$16,194 | — | 01 Apr 2023 | |
| Takeo Mukai |
3/4/5
|
CFO |
—
class O/S missing
|
72,874
|
$15,304 | — | 01 Mar 2024 | |
| Kevin Mathews |
3/4/5
|
SVP, Commercial |
—
class O/S missing
|
61,106
|
$11,549 | — | 07 Jan 2024 | |
| John F. Sheridan |
3/4/5
|
Director |
—
class O/S missing
|
24,347
|
$4,602 | — | 15 Jun 2023 | |
| Jason K. Garland |
3/4/5
|
Director |
—
class O/S missing
|
22,400
|
$4,234 | — | 15 Jun 2023 | |
| Niamh Louise Pellegrini |
3/4/5
|
Director |
—
class O/S missing
|
20,972
|
$3,964 | — | 15 Jun 2023 | |
| Andrew ElBardissi |
3/4/5
|
Director |
—
class O/S missing
|
20,822
|
$3,935 | — | 15 Jun 2023 | |
| David P. Bonita |
3/4/5
|
Director |
—
class O/S missing
|
20,822
|
$3,935 | — | 15 Jun 2023 | |
| Shaden Marzouk |
3/4/5
|
Director |
—
class O/S missing
|
20,822
|
$3,935 | — | 15 Jun 2023 |
Institutional Holders of Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB) as of Q1 2024
As of 31 Mar 2024,
Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,592,463 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA SECURITIES, LLC, STATE STREET CORP, NORTHERN TRUST CORP, and MORGAN STANLEY.
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
27
Q1 2024 holders
21
Holder diff
-6
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.